Page last updated: 2024-10-30

meclizine and Muscular Dystrophy, Duchenne

meclizine has been researched along with Muscular Dystrophy, Duchenne in 1 studies

Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.

Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kawamura, Y1
Hida, T1
Ohkawara, B1
Matsushita, M1
Kobayashi, T1
Ishizuka, S1
Hiraiwa, H1
Tanaka, S1
Tsushima, M1
Nakashima, H1
Ito, K1
Imagama, S1
Ito, M1
Masuda, A1
Ishiguro, N1
Ohno, K1

Other Studies

1 other study available for meclizine and Muscular Dystrophy, Duchenne

ArticleYear
Meclozine ameliorates skeletal muscle pathology and increases muscle forces in mdx mice.
    Biochemical and biophysical research communications, 2022, 02-12, Volume: 592

    Topics: Animals; Cell Differentiation; Cell Proliferation; Cell Survival; Extracellular Signal-Regulated MAP

2022